Pumpinheart has created PReduction, a minimally invasive catheter‑based diastolic heart pump that augments left‑ventricular filling and reduces myocardial oxygen demand in patients with heart failure with preserved ejection fraction (HFpEF). The device includes embedded pressure sensors and a closed‑loop control algorithm that automatically adjusts flow, while wireless telemetry streams real‑time hemodynamic data to a cloud platform for remote clinician monitoring and integration with electronic health records. It targets cardiology departments, heart‑failure clinics, and hospital systems seeking a less invasive circulatory support solution.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with heart failure with preserved ejection fraction (HFpEF) have limited therapeutic options because existing treatments do not adequately improve diastolic filling or reduce cardiac workload, and invasive mechanical support devices are often unsuitable for this population.
Solution
Pumpinheart has developed PReduction, a minimally invasive diastolic heart pump designed to augment left‑ventricular filling during diastole and lower myocardial oxygen demand in HFpEF patients. The device is implanted via a small catheter‑based procedure and operates without the need for external power sources, providing continuous support while preserving native systolic function. Integrated pressure sensors monitor intracardiac hemodynamics in real time, enabling closed‑loop adjustment of pump flow to match patient‑specific physiology. Data are transmitted wirelessly to a secure cloud platform where clinicians can review trends, adjust therapy parameters remotely, and integrate results into existing electronic health record systems. By targeting the underlying diastolic dysfunction, PReduction aims to improve exercise capacity, reduce hospitalizations, and enhance quality of life for HFpEF patients.
Target Audience
Primary customers are cardiology departments and heart‑failure clinics treating HFpEF patients, as well as medical device distributors and hospital systems seeking minimally invasive circulatory support solutions.
Features
- Catheter‑based implantation technique that avoids open‑heart surgery
- Diastolic‑phase pump that augments left‑ventricular filling without interfering with systolic contraction
- Embedded pressure and flow sensors for real‑time hemodynamic monitoring
- Closed‑loop control algorithm that automatically adjusts pump output based on sensed cardiac pressures
- Wireless telemetry to a cloud‑hosted analytics dashboard for remote clinician oversight
- Compatibility with standard EHR interfaces via FHIR‑based APIs
- Designed for long‑term implantation with low power consumption and biocompatible materials